logo
ENTITY
Daiichi Sankyo

Daiichi Sankyo (4568 JP)

124
Analysis
Health Care • Japan
Daiichi Sankyo Co, Ltd is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
more
Refresh
bullish•Thematic (Sector/Industry)
•25 Sep 2018 19:48

Japan Pharma: Core Coverage Investment Thesis and Valuations (III/​III)

Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...

Logo
Share
bullish•Thematic (Sector/Industry)
•25 Sep 2018 19:43

Japan Pharma: Core Coverage Investment Thesis and Valuations (II/​III)

Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...

Logo
Share
bullish•Thematic (Sector/Industry)
•25 Sep 2018 19:38

Japan Pharma: Core Coverage Investment Thesis and Valuations (I/III)

Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...

Logo
Share
bearish•Fast Retailing
•23 Jul 2018 07:38

JAPAN PASSIVE:  The Nikkei 225 Baskets if BOJ Changes

Last week in JAPAN PASSIVE:  BOJ Heading For Trouble with Nikkei 225 I discussed the BOJ's past and current ETF purchasing selection, ownership,...

Logo
Travis Lundy
556 Views
Share
bullish•Daiichi Sankyo
•28 Jun 2018 19:36

Series of R&D Positives After Recent Late Stage Setbacks, However, Too Early to Draw Firm Conclusion

Cost rationalization effort to drive industry leading earnings growth (on almost flat sales) over next 3-5 years. We reiterate our Neutral rating...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7

x